Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
- First Posted Date
- 2009-08-24
- Last Posted Date
- 2009-09-03
- Lead Sponsor
- NuRx Pharmaceuticals, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT00964132
- Locations
- 🇺🇸
Dr. Pandit, Fountain Valley, California, United States
🇺🇸UCSD Moores Cancer Center, La Jolla,, California, United States
🇺🇸USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia
Phase 2
- Conditions
- Acute Promyelocytic Leukemia
- Interventions
- Drug: NRX 195183 Soft Gelatin Capsule
- First Posted Date
- 2008-05-12
- Last Posted Date
- 2008-05-12
- Lead Sponsor
- NuRx Pharmaceuticals, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT00675870
- Locations
- 🇺🇸
Sarcoma Oncology Center, Santa Monica,, California, United States
News
No news found